These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9756270)

  • 1. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Elhelw BA; Shaarawy M
    Hum Reprod; 1998 Aug; 13(8):2068-71. PubMed ID: 9756270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome.
    Manolopoulos K; Lang U; Gips H; Braems GA
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):226-31. PubMed ID: 11788177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).
    Farkas B; Boldizsar F; Bohonyi N; Farkas N; Marczi S; Kovacs GL; Bodis J; Koppan M
    J Ovarian Res; 2020 Mar; 13(1):25. PubMed ID: 32138790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro fertilization and the ovarian hyperstimulation syndrome.
    MacDougall MJ; Tan SL; Jacobs HS
    Hum Reprod; 1992 May; 7(5):597-600. PubMed ID: 1639974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
    Itskovitz-Eldor J; Kol S; Lewit N; Sealey JE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):461-4. PubMed ID: 9024237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study.
    Orvieto R; Voliovitch I; Fishman P; Ben-Rafael Z
    Hum Reprod; 1995 Jan; 10(1):24-7. PubMed ID: 7745063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Friedler S; Nisman B; Barak V
    Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence.
    Loret de Mola JR; Baumgardner GP; Goldfarb JM; Friedlander MA
    Hum Reprod; 1996 Jul; 11(7):1377-80. PubMed ID: 8671470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome].
    Fan Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):647-50. PubMed ID: 11930686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y; Barak V; Nisman B; Schenker JG
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.
    Delvigne A; Demoulin A; Smitz J; Donnez J; Koninckx P; Dhont M; Englert Y; Delbeke L; Darcis L; Gordts S
    Hum Reprod; 1993 Sep; 8(9):1353-60. PubMed ID: 8253917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood concentrations of inhibin B are elevated during gonadotrophin stimulation in patients who later develop ovarian OHSS and inhibin A concentrations are elevated after OHSS onset.
    Enskog A; Nilsson L; Brännström M
    Hum Reprod; 2000 Mar; 15(3):532-8. PubMed ID: 10686192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment.
    Egbase PE; Al Sharhan M; Berlingieri P; Grudzinskas JG
    Hum Reprod; 2000 Oct; 15(10):2082-6. PubMed ID: 11006177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyperstimulation syndrome.
    Daniel Y; Geva E; Amit A; Eshed-Englender T; Bar-Am A; Lessing JB
    Am J Reprod Immunol; 2001 Mar; 45(3):154-60. PubMed ID: 11270640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.